Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

Schedule of computation of basic and diluted net loss per share

The following table sets forth the computation of basic and diluted net loss per share for the three and six months ended June 30, 2024, and 2023 (in thousands, except number of shares):

	Three months ended June 30,				Six months ended June 30,
	2024		2023		2024		2023
Numerator:
Net loss	$	(16,943)	$	(23,824)	$	(32,463)	$	(42,047)
Net loss attributable to noncontrolling interest	12		22		43		65
Net loss attributable to Barinthus Biotherapeutics plc shareholders	$	(16,931)	$	(23,802)	$	(32,420)	$	(41,982)
Denominator:
Weighted-average ordinary shares outstanding, basic	39,041,111		38,407,672		38,907,296		38,211,625
Weighted-average ordinary shares outstanding, diluted	39,041,111		38,407,672		38,907,296		38,211,625
Net loss per share attributable to ordinary shareholders, basic	$	(0.43)	$	(0.62)	$	(0.83)	$	(1.10)
Net loss per share attributable to ordinary shareholders, diluted	$	(0.43)	$	(0.62)	$	(0.83)	$	(1.10)